Search Within

Emmet John Jordan

Formats
  1. Meeting Abstract (24)
  2. Journal Article (22)
  3. Research Letter (1)
Groups
  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (45)
  3. Department of Pathology and Laboratory Medicine (37)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (36)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (31)

More Groups

People
  1. Michael Berger (30)
  2. David Solit (29)
  3. Gopakumar Iyer (17)
  4. Maeve Lowery (16)
  5. Maria Arcila (16)
  6. Eileen O'Reilly (14)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (5)
  5. 2018 (7)
  6. 2017 (10)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (6)
  3. Laboratory Investigation (3)
  4. Modern Pathology (3)
  5. Cancer (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (8)
  3. Nature Publishing Group (6)
  4. Nature Research (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • AKT1 E17K inhibits cancer cell migration by abrogating β-catenin signaling
    Journal Article

    Gao, S. P.; Kiliti, A. J.; Zhang, K.; Vasani, N.; Mao, N.; Jordan, E.; Wise, H. C.; Shrestha Bhattarai, T.; Hu, W.; Dorso, M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings
    Journal Article

    Maynard, H.; Stadler, Z. K.; Berger, M. F.; Solit, D. B.; Ly, M.; Lowery, M. A.; Mandelker, D.; Zhang, L.; Jordan, E.; El Dika, I.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
    Journal Article

    Lowery, M. A.; Goff, L. W.; Keenan, B. P.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O’Reilly, E. M.; Harding, J. J.; Kemeny, N.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Clinical haematological biomarkers: Derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) and their relationship to survival outcomes in non small cell lung cancer (NSCLC) treated with immunotherapy: A multicenter review
    Meeting Abstract

    Dennehy, C.; McMahon, E.; Power, D. G.; O'Reilly, S.; Collins, D. C.; O'Mahony, D.; Horgan, A. M.; O'Connor, M.; Jordan, E.; Calvert, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer
    Journal Article

    Li, Q.; Damish, A. W.; Frazier, Z.; Liu, D.; Reznichenko, E.; Kamburov, A.; Bell, A.; Zhao, H.; Jordan, E. J.; Gao, S. P.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save